Evidence map›Paper›PMID 38172751›Full record

ArticleBMC surgery2024

Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up.

Mohammad Kermansaravi, Rohollah Valizadeh, Masoumeh Shahsavan, Seyyed Adel Maleknia, Foolad Eghbali, Abdolreza Pazouki, Shahab Shahabi Shahmiri

Open access · goldAbstract read
In one paragraph

Article in BMC surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mohammad Kermansaravi *Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. mkermansaravi@yahoo.com.
Rohollah Valizadeh *Urmia University of Medical Sciences, Urmia, Iran.
Masoumeh ShahsavanMinimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
Seyyed Adel MalekniaMinimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
Foolad EghbaliDepartment of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abdolreza PazoukiDepartment of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Shahab Shahabi ShahmiriDepartment of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, Rasool-e Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. shshahabi@yahoo.com.
Iran University of Medical Sciences · IRRasool Akram Hospital · IRUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with class I obesity may need metabolic and bariatric surgery (MBS) in the presence of obesity-associated medical problems, but MBS in this class of obesity is under debate. This study aimed to investigate the efficacy and safety of MBS in patients with class I obesity. METHODS AND MATERIALS: This study was a historical cohort carried out on 112 patients with class I obesity with body mass index (BMI) of 30-35 kg/m

resultsMean age of the patients was 38.10 ± 10.04 years; mean BMI was 32.96 ± 1.35 kg/m

conclusionMBS is safe and effective in class I obesity and can be considered in selected patients with obesity-associated medical problems.

Indexed as

Bariatric SurgeryDiabetes Mellitus, Type 2DyslipidemiasGastroesophageal RefluxHypertensionObesity, MorbidSleep Apnea, ObstructiveAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedObesityRetrospective StudiesTreatment OutcomeBariatric SurgeryLow BMIMetabolic SurgeryObesity

Identifiers

PMID38172751
PMCPMC10765846
OpenAlexW4390571168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.